18 results
S-3
EX-4.3
ENTA
Enanta Pharmaceuticals Inc
22 Nov 23
Shelf registration
4:38pm
for transfer, exchange, payment, replacement or cancellation and shall destroy such canceled Securities (subject to the record retention requirements
8-K
EX-10.1
ENTA
Enanta Pharmaceuticals Inc
27 Apr 23
Non-Dilutive and Strengthens Balance Sheet
4:43pm
, with such cooperation to include (i) the retention of and the provision to the Indemnifying Party of records and information that are reasonably relevant to such Third
8-K
EX-1.1
ENTA
Enanta Pharmaceuticals Inc
26 Aug 22
Entry into a Material Definitive Agreement
4:10pm
or retention where required and legending, and each such Free Writing Prospectus, as of its issue date and at all subsequent times through the completion
8-K
EX-10.3
ENTA
Enanta Pharmaceuticals Inc
17 May 22
Entry into a Material Definitive Agreement
4:37pm
for any damages resulting from Landlord’s retention and/or disposition of such property. All obligations of Tenant hereunder not fully performed
S-3ASR
EX-4.3
0vjlr6l
9 Aug 21
Automatic shelf registration
4:11pm
DEFR14A
bw9h4
28 Jan 21
Revised proxy
4:01pm
DEF 14A
k2p r3cc6
10 Jan 14
Definitive proxy
12:00am
424B4
z93wh32qq3e3oi
21 Mar 13
Prospectus supplement with pricing info
12:00am
S-1/A
pnrdf3q
16 Nov 12
IPO registration (amended)
12:00am
- Prev
- 1
- Next